Horizon Therapeutics Public Limited Company HZNP
$ 116.3
0.0%
Quarterly report 2023-Q2
added 08-08-2023
Horizon Therapeutics Public Limited Company Cash Flow 2011-2024 | HZNP
Annual Cash Flow Horizon Therapeutics Public Limited Company
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
1.26 B | 1.04 B | 556 M | 426 M | 195 M | 284 M | 369 M | - | 27.5 M | -54.3 M | -76.6 M | -41.5 M |
Depreciation & Amortization |
390 M | 354 M | 279 M | 237 M | 250 M | 256 M | 222 M | 138 M | 34 M | 9.31 M | 5.54 M | 4.2 M |
Accounts Payables |
156 M | 30.1 M | 37.7 M | 21.5 M | 30.3 M | 34.7 M | 52.5 M | 16.6 M | 21 M | 9.92 M | 5.99 M | 8.17 M |
Accounts Receivables |
676 M | 633 M | 660 M | 409 M | 465 M | 405 M | 306 M | 210 M | 73.9 M | 16 M | 3.46 M | 2.37 M |
Total Inventories |
170 M | 226 M | 75.3 M | 53.8 M | 50.8 M | 61.7 M | 175 M | 18.4 M | 16.9 M | 8.7 M | 5.24 M | 1.2 M |
All numbers in USD currency
Quarterly Cash Flow Horizon Therapeutics Public Limited Company
2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | 86.3 M | - | 831 M | - | 216 M | - | 497 M | - | -3.73 M | - | 146 M | 37 M | -62.6 M | - | 235 M | 147 M | 56.2 M | - | 85.8 M | 974 K | -60.8 M | - | 141 M | 72.7 M | - | - | - | - | - | - | - | - | - | - | - | - | -757 K | - | -43.1 M | -33.7 M | -22.8 M | - | -59.5 M | -36.6 M | -20.8 M | - | -26.9 M | -10.6 M | -6.5 M |
Depreciation & Amortization |
6.7 M | 94.9 M | - | 292 M | 6.1 M | 95.1 M | - | 257 M | 3.39 M | 70.8 M | - | 210 M | 139 M | 65.7 M | - | 177 M | 118 M | 58.9 M | - | 187 M | 124 M | 62.4 M | - | 213 M | 143 M | 71.5 M | - | 154 M | 103 M | 50.6 M | - | 94 M | 50.7 M | 18.3 M | - | 17.7 M | 10.8 M | 5.4 M | - | 5.84 M | 3.86 M | 1.92 M | - | 3.65 M | 2.14 M | 1.08 M | - | 3.07 M | 2.04 M | 1.02 M |
Accounts Payables |
85.5 M | 76.6 M | 156 M | 32.1 M | - | 67 M | 30.1 M | 50.7 M | 51.9 M | 43 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 34.7 M | 34.7 M | 34.7 M | 34.7 M | 52.5 M | 52.5 M | 52.5 M | 52.5 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 21 M | 21 M | 21 M | 21 M | 9.92 M | 9.92 M | 9.92 M | 9.92 M | 5.99 M | 5.99 M | 5.99 M | 5.99 M | 8.17 M | 8.17 M | 8.17 M | 8.17 M |
Accounts Receivables |
717 M | 625 M | 676 M | 646 M | - | 685 M | 633 M | 775 M | 735 M | 443 M | 660 M | 660 M | 660 M | 660 M | 409 M | 409 M | 409 M | 409 M | 465 M | 465 M | 465 M | 465 M | 405 M | 405 M | 405 M | 405 M | 306 M | 306 M | 306 M | 306 M | 210 M | 210 M | 210 M | 210 M | 73.9 M | 73.9 M | 73.9 M | 73.9 M | 16 M | 16 M | 16 M | 16 M | 3.46 M | 3.46 M | 3.46 M | 3.46 M | 2.37 M | 2.37 M | 2.37 M | 2.37 M |
Total Inventories |
170 M | 164 M | 170 M | 190 M | - | 227 M | 226 M | 237 M | 259 M | 238 M | 75.3 M | 75.3 M | 75.3 M | 75.3 M | 53.8 M | 53.8 M | 53.8 M | 53.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 175 M | 175 M | 175 M | 175 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M |
All numbers in USD currency